BritePearโ€บResearchโ€บKLOW Blend
Research ยท Skin & Recovery Blends
Compounding Gray Area

KLOW, The Four-Peptide Blend

GLOW plus KPV. The same repair-and-skin foundation, with an added anti-inflammatory peptide layered on top.

๐Ÿ Pear It Down โ€”

KLOW is GLOW (BPC-157, TB-500, GHK-Cu) with a fourth peptide, KPV, added. KPV is a tripeptide studied for anti-inflammatory and antimicrobial effects on skin. The "K" in KLOW comes from KPV. Like GLOW, this is a compounding pharmacy blend, not a separately studied formula.

Not medical advice. Educational information reflecting personal research and transparency. KLOW is not FDA-approved as a blend or as individual components for this use. Always work with a qualified healthcare provider before starting any peptide protocol.

KLOW is the four-peptide extension of GLOW. If you understand GLOW, the addition here is one component: KPV, added specifically for its anti-inflammatory profile on skin.

The Fourth Component

What KPV Adds

KPV is a tripeptide fragment derived from alpha-melanocyte-stimulating hormone (ฮฑ-MSH). Research has focused on its anti-inflammatory and antimicrobial properties, with studies showing it can reduce inflammatory markers in skin and gut tissue models without the immunosuppressive effects of stronger anti-inflammatory compounds.[1]

In the context of this blend, KPV is added alongside BPC-157, TB-500, and GHK-Cu (see the full GLOW blend profile โ†’ for those three) specifically for people whose skin or recovery concerns include an inflammatory component, redness, irritation, breakouts, that the other three don't directly target.

GLOW vs. KLOW

Which One, and Why

The practical difference compounding pharmacies and the people requesting these blends describe: GLOW is the baseline repair-and-collagen stack. KLOW is GLOW plus an anti-inflammatory layer. Someone dealing primarily with skin laxity or tissue repair after weight loss might reach for GLOW. Someone also dealing with inflammatory skin concerns, redness, sensitivity, would consider KLOW instead.

Neither blend has been studied as a combination in a clinical trial. The reasoning is built from the individual research bases of four separately-studied peptides, not from a trial of the four-peptide combination itself.

"KLOW is the request I hear most often from the skin-focused side of the peptide community. It is exactly what it sounds like: the GLOW foundation with one more targeted ingredient. Understanding each piece individually is what actually lets you have an informed conversation with a compounding pharmacist or physician about whether you need all four."

โš  FDA / Regulatory StatusNone of the four components, individually or combined, are FDA-approved for this or any human therapeutic use. As with GLOW, sourcing and compounding quality vary by pharmacy. Always verify sourcing and discuss with a physician before pursuing any blend protocol.
Cliff's Note

Same note as GLOW: this is Cheryl's research territory. The individual peptide profiles are worth reading before considering the blend. See the Skin page for how she thinks about sequencing and combining these in practice.

Sources & Citations

  1. Catania A, et al. (2010). The melanocortin system in control of inflammation. Scientific World Journal, 10, 1840โ€“1853.